Janssen Announces Positive CHMP Opinion for JULUCATM ▼ (dolutegravir/rilpivirine)

If approved, stable, virologically suppressed adults living with HIV-1 could have the option to switch to a single-pill, two-drug regimen

Source: Johnson and Johnson - March 23, 2018 Category: Pharmaceuticals Source Type: news